Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Brain Research
|
June 7, 2017
Genetic deletion of GPR52 enhances the locomotor-stimulating effect of an adenosine A<sub>2A</sub> receptor antagonist in mice: A potential role of GPR52 in the function of striatopallidal neurons
Keiji Nishiyama, Hirobumi Suzuki, Minoru Maruyama, et al.
Biological & Pharmaceutical Bulletin
|
August 2, 2007
Biopanning of antibody-phage clones using immunoplates coated with gel slices of electrophoresis: immunogel-biopanning
Takayuki Hamasaki, Shunsuke Uchida, Tomoki Yoshihara, et al.
Journal of Biochemistry
|
May 23, 2003
Human Fc epsilon RIalpha-specific human single-chain Fv (scFv) antibody with antagonistic activity toward IgE/Fc epsilon RIalpha-binding
Shuhei Hashiguchi, Toshihiro Nakashima, Aya Nitani, et al.
Journal of Immunological Methods
|
January 27, 2020
Development of novel highly sensitive methods to detect endogenous cGAMP in cells and tissue
Shuuichi Miyakawa, Toshitake Okui, Tsubasa Shiraishi, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
June 15, 2018
Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development
Yana Wang, Tomoki Yoshihara, Samson King, et al.
Journal of Biochemistry
|
January 5, 2008
Immunoreactivity of phage library-derived human single-chain antibodies to amyloid beta conformers in vitro
Tomoki Yoshihara, Sho Takiguchi, Akifumi Kyuno, et al.
Frontiers in Neuroscience
|
January 1, 2021
Anti-sortilin1 Antibody Up-Regulates Progranulin <i>via</i> Sortilin1 Down-Regulation
Shuuichi Miyakawa, Hiroyuki Sakuma, Dnyaneshwar Warude, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 12, 2019
SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity
Hikaru Ueno, Ryo Ito, Shin-Ichi Abe, et al.
Communications Biology
|
May 10, 2023
Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells
Marenori Kojima, Katsuya Suzuki, Masaru Takeshita, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Brain Research
|
June 7, 2017
Genetic deletion of GPR52 enhances the locomotor-stimulating effect of an adenosine A<sub>2A</sub> receptor antagonist in mice: A potential role of GPR52 in the function of striatopallidal neurons
Keiji Nishiyama, Hirobumi Suzuki, Minoru Maruyama, et al.
Biological & Pharmaceutical Bulletin
|
August 2, 2007
Biopanning of antibody-phage clones using immunoplates coated with gel slices of electrophoresis: immunogel-biopanning
Takayuki Hamasaki, Shunsuke Uchida, Tomoki Yoshihara, et al.
Journal of Biochemistry
|
May 23, 2003
Human Fc epsilon RIalpha-specific human single-chain Fv (scFv) antibody with antagonistic activity toward IgE/Fc epsilon RIalpha-binding
Shuhei Hashiguchi, Toshihiro Nakashima, Aya Nitani, et al.
Journal of Immunological Methods
|
January 27, 2020
Development of novel highly sensitive methods to detect endogenous cGAMP in cells and tissue
Shuuichi Miyakawa, Toshitake Okui, Tsubasa Shiraishi, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
June 15, 2018
Automated High-Throughput Flow Cytometry for High-Content Screening in Antibody Development
Yana Wang, Tomoki Yoshihara, Samson King, et al.
Journal of Biochemistry
|
January 5, 2008
Immunoreactivity of phage library-derived human single-chain antibodies to amyloid beta conformers in vitro
Tomoki Yoshihara, Sho Takiguchi, Akifumi Kyuno, et al.
Frontiers in Neuroscience
|
January 1, 2021
Anti-sortilin1 Antibody Up-Regulates Progranulin <i>via</i> Sortilin1 Down-Regulation
Shuuichi Miyakawa, Hiroyuki Sakuma, Dnyaneshwar Warude, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 12, 2019
SCO-267, a GPR40 Full Agonist, Improves Glycemic and Body Weight Control in Rat Models of Diabetes and Obesity
Hikaru Ueno, Ryo Ito, Shin-Ichi Abe, et al.
Communications Biology
|
May 10, 2023
Anti-human-TIGIT agonistic antibody ameliorates autoimmune diseases by inhibiting Tfh and Tph cells and enhancing Treg cells
Marenori Kojima, Katsuya Suzuki, Masaru Takeshita, et al.
Page
of 1